Skip to content
10-K

Annual Report

ASSERTIO THERAPEUTICS, INC.

0001005201-20-000021

← back to feed
Filed
Mar 10, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Mar 2, 2020 81.29M sh
Shares Diluted FY 2019 · Dec 31, 2019 70.72M sh
Shares Diluted FY 2019 · Dec 31, 2018 64.21M sh
Shares Diluted FY 2019 · Dec 31, 2017 62.7M sh
Capex FY 2019 · Dec 31, 2019 $1.48M
Capex FY 2019 · Dec 31, 2018 $5.51M
Capex FY 2019 · Dec 31, 2017 $666K
Operating Cash Flow FY 2019 · Dec 31, 2019 $90.48M
Operating Cash Flow FY 2019 · Dec 31, 2018 $72.5M
Operating Cash Flow FY 2019 · Dec 31, 2017 $62.17M
Cash And Equivalents FY 2019 · Dec 31, 2019 $42.11M
Cash And Equivalents FY 2019 · Dec 31, 2018 $110.95M
Stockholders Equity FY 2019 · Dec 31, 2019 $57.96M
Stockholders Equity FY 2019 · Dec 31, 2018 $220.34M
Stockholders Equity FY 2019 · Dec 31, 2017 $169.51M
Stockholders Equity FY 2019 · Dec 31, 2016 $250.79M
Current Liabilities FY 2019 · Dec 31, 2019 $184.55M
Current Liabilities FY 2019 · Dec 31, 2018 $246.04M
Total Liabilities FY 2019 · Dec 31, 2019 $469.21M
Total Liabilities FY 2019 · Dec 31, 2018 $712.53M
Current Assets FY 2019 · Dec 31, 2019 $103.95M
Current Assets FY 2019 · Dec 31, 2018 $208.11M
Total Assets FY 2019 · Dec 31, 2019 $527.17M
Total Assets FY 2019 · Dec 31, 2018 $932.87M
Eps Diluted FY 2019 · Dec 31, 2019 −$2.65
Eps Diluted FY 2019 · Dec 31, 2019 −$3.07
Eps Diluted FY 2019 · Sep 30, 2019 $0.05
Eps Diluted FY 2019 · Jun 30, 2019 −$0.21
Eps Diluted FY 2019 · Mar 31, 2019 −$0.22
Eps Diluted FY 2019 · Dec 31, 2018 −$0.38
Eps Diluted FY 2019 · Dec 31, 2018 $0.57
Eps Diluted FY 2019 · Sep 30, 2018 $0.65
Eps Diluted FY 2019 · Jun 30, 2018 −$0.33
Eps Diluted FY 2019 · Mar 31, 2018 $0.48
Eps Diluted FY 2019 · Dec 31, 2017 −$1.63
Eps Basic FY 2019 · Dec 31, 2019 −$2.65
Eps Basic FY 2019 · Dec 31, 2019 −$3.07
Eps Basic FY 2019 · Sep 30, 2019 $0.05
Eps Basic FY 2019 · Jun 30, 2019 −$0.21
Eps Basic FY 2019 · Mar 31, 2019 −$0.22
Eps Basic FY 2019 · Dec 31, 2018 −$0.38
Eps Basic FY 2019 · Dec 31, 2018 $0.58
Eps Basic FY 2019 · Sep 30, 2018 $0.76
Eps Basic FY 2019 · Jun 30, 2018 −$0.33
Eps Basic FY 2019 · Mar 31, 2018 $0.53
Eps Basic FY 2019 · Dec 31, 2017 −$1.63
Sga Expense FY 2019 · Dec 31, 2019 $108.87M
Sga Expense FY 2019 · Dec 31, 2018 $119.22M
Sga Expense FY 2019 · Dec 31, 2017 $195.7M
Net Income FY 2019 · Dec 31, 2019 −$192.63M
Net Income FY 2019 · Dec 31, 2019 −$217.2M
Net Income FY 2019 · Sep 30, 2019 $3.33M
Net Income FY 2019 · Jun 30, 2019 −$13.61M
Net Income FY 2019 · Mar 31, 2019 −$14.3M
Net Income FY 2019 · Dec 31, 2018 −$24.14M
Net Income FY 2019 · Dec 31, 2018 $36.91M
Net Income FY 2019 · Sep 30, 2018 $48.27M
Net Income FY 2019 · Jun 30, 2018 −$21.05M
Net Income FY 2019 · Mar 31, 2018 $33.82M
Net Income FY 2019 · Dec 31, 2017 −$102.5M
Operating Income FY 2019 · Dec 31, 2019 −$190.99M
Operating Income FY 2019 · Dec 31, 2019 −$194.43M
Operating Income FY 2019 · Sep 30, 2019 −$10.13M
Operating Income FY 2019 · Jun 30, 2019 $3.62M
Operating Income FY 2019 · Mar 31, 2019 $3.07M
Operating Income FY 2019 · Dec 31, 2018 −$13.08M
Operating Income FY 2019 · Dec 31, 2018 $43.66M
Operating Income FY 2019 · Sep 30, 2018 $9.63M
Operating Income FY 2019 · Jun 30, 2018 −$4.23M
Operating Income FY 2019 · Mar 31, 2018 $51.34M
Operating Income FY 2019 · Dec 31, 2017 −$42.18M
Revenue FY 2019 · Dec 31, 2019 $59.23M
Revenue FY 2019 · Dec 31, 2019 $229.5M
Revenue FY 2019 · Sep 30, 2019 $55.15M
Revenue FY 2019 · Jun 30, 2019 $57.2M
Revenue FY 2019 · Mar 31, 2019 $57.93M
Revenue FY 2019 · Dec 31, 2018 $42.6M
Revenue FY 2019 · Dec 31, 2018 $311.77M
Revenue FY 2019 · Sep 30, 2018 $77.49M
Revenue FY 2019 · Jun 30, 2018 $63.27M
Revenue FY 2019 · Mar 31, 2018 $128.4M
Revenue FY 2019 · Dec 31, 2017 $380.72M